Last 12 months
Inside the activity.
2 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 7 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 13, 2023 Filed Jan 17, 2023 17:00 UTC |
Khayal Tamer IChief Commercial Officer
|
SaleCommon Stock | 5,900 | $60.20 | $355,180.00 |
DisclosureSEC source: 0000899243-23-001859 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.00 to $60.73, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:00 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionCommon Stock | 5,900 | $16.00 | $94,400.00 |
DisclosureSEC source: 0000899243-23-001859 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 17:00 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,100 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-23-001013 · doc4.xml · derivative · entry 7 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,185 Underlying: Common Stock · 4,100 shares Expires 2029-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5 · derivative.exercise_date: The option vests in equal monthly installments over four years beginning on the date of grant, May 1, 2019. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 17:00 UTC |
Khayal Tamer IChief Commercial Officer
|
SaleCommon Stock | 500 | $62.79 | $31,395.00 |
DisclosureSEC source: 0000899243-23-001013 · doc4.xml · nonDerivative · entry 4 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.52 to $62.96, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 17:00 UTC |
Khayal Tamer IChief Commercial Officer
|
SaleCommon Stock | 2,700 | $61.99 | $167,373.00 |
DisclosureSEC source: 0000899243-23-001013 · doc4.xml · nonDerivative · entry 3 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.45 to $62.40, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 17:00 UTC |
Khayal Tamer IChief Commercial Officer
|
SaleCommon Stock | 900 | $60.93 | $54,837.00 |
DisclosureSEC source: 0000899243-23-001013 · doc4.xml · nonDerivative · entry 2 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.42 to $61.37, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 17:00 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionCommon Stock | 4,100 | $16.00 | $65,600.00 |
DisclosureSEC source: 0000899243-23-001013 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:30 UTC |
DAMME LAURAVP, Clinical Affairs
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,740 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-22-038829 · doc4.xml · derivative · entry 9 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,063 Underlying: Common Stock · 4,740 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:30 UTC |
DAMME LAURAVP, Clinical Affairs
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 250 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-22-038829 · doc4.xml · derivative · entry 8 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,803 Underlying: Common Stock · 250 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:30 UTC |
DAMME LAURAVP, Clinical Affairs
|
SaleCommon Stock | 4,740 | $58.96 | $279,470.40 |
DisclosureSEC source: 0000899243-22-038829 · doc4.xml · nonDerivative · entry 6 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $58.92 to $59.32, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:30 UTC |
DAMME LAURAVP, Clinical Affairs
|
Exercise / conversionCommon Stock | 4,740 | $38.46 | $182,300.40 |
DisclosureSEC source: 0000899243-22-038829 · doc4.xml · nonDerivative · entry 5 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:30 UTC |
DAMME LAURAVP, Clinical Affairs
|
SaleCommon Stock | 250 | $60.02 | $15,005.00 |
DisclosureSEC source: 0000899243-22-038829 · doc4.xml · nonDerivative · entry 4 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.00 to $60.35, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:30 UTC |
DAMME LAURAVP, Clinical Affairs
|
Exercise / conversionCommon Stock | 250 | $38.46 | $9,615.00 |
DisclosureSEC source: 0000899243-22-038829 · doc4.xml · nonDerivative · entry 3 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:30 UTC |
DAMME LAURAVP, Clinical Affairs
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,947 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-22-038829 · doc4.xml · derivative · entry 7 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,053 Underlying: Common Stock · 5,947 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:30 UTC |
DAMME LAURAVP, Clinical Affairs
|
SaleCommon Stock | 5,947 | $62.43 | $371,271.21 |
DisclosureSEC source: 0000899243-22-038829 · doc4.xml · nonDerivative · entry 2 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.00 to $62.91, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:30 UTC |
DAMME LAURAVP, Clinical Affairs
|
Exercise / conversionCommon Stock | 5,947 | $38.46 | $228,721.62 |
DisclosureSEC source: 0000899243-22-038829 · doc4.xml · nonDerivative · entry 1 DAMME LAURA · CIK 0001784433 · VP, Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:30 UTC |
Provost MiriamVP, Global Regulatory Affairs
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,918 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-22-038601 · doc4.xml · derivative · entry 4 Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,105 Underlying: Common Stock · 5,918 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:30 UTC |
Provost MiriamVP, Global Regulatory Affairs
|
SaleCommon Stock | 1,620 | $63.00 | $102,060.00 |
DisclosureSEC source: 0000899243-22-038601 · doc4.xml · nonDerivative · entry 3 Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,154 F1 · kind: The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.72 to $63.32, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:30 UTC |
Provost MiriamVP, Global Regulatory Affairs
|
SaleCommon Stock | 2,695 | $62.24 | $167,736.80 |
DisclosureSEC source: 0000899243-22-038601 · doc4.xml · nonDerivative · entry 2 Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,774 F1 · kind: The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.70 to $62.69, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:30 UTC |
Provost MiriamVP, Global Regulatory Affairs
|
Exercise / conversionCommon Stock | 5,918 | $38.46 | $227,606.28 |
DisclosureSEC source: 0000899243-22-038601 · doc4.xml · nonDerivative · entry 1 Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 21:30 UTC |
Provost MiriamVP, Global Regulatory Affairs
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,149 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-22-038318 · doc4.xml · derivative · entry 8 Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,226 Underlying: Common Stock · 1,149 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 21:30 UTC |
Provost MiriamVP, Global Regulatory Affairs
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,977 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-22-038318 · doc4.xml · derivative · entry 7 Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,023 Underlying: Common Stock · 3,977 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 21:30 UTC |
Provost MiriamVP, Global Regulatory Affairs
|
SaleCommon Stock | 567 | $59.00 | $33,453.00 |
DisclosureSEC source: 0000899243-22-038318 · doc4.xml · nonDerivative · entry 5 Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,551 F1 · kind: The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 21:30 UTC |
Provost MiriamVP, Global Regulatory Affairs
|
Exercise / conversionCommon Stock | 1,149 | $16.14 | $18,544.86 |
DisclosureSEC source: 0000899243-22-038318 · doc4.xml · nonDerivative · entry 4 Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 21:30 UTC |
Provost MiriamVP, Global Regulatory Affairs
|
SaleCommon Stock | 3,046 | $59.00 | $179,714.00 |
DisclosureSEC source: 0000899243-22-038318 · doc4.xml · nonDerivative · entry 3 Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,969 F1 · kind: The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 21:30 UTC |
Provost MiriamVP, Global Regulatory Affairs
|
Exercise / conversionCommon Stock | 3,977 | $38.46 | $152,955.42 |
DisclosureSEC source: 0000899243-22-038318 · doc4.xml · nonDerivative · entry 2 Provost Miriam · CIK 0001773663 · VP, Global Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 05, 2022 Filed Dec 5, 2022 22:33 UTC |
Carey John FVP of Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 36 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · derivative · entry 14 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 05, 2022 Filed Dec 5, 2022 22:33 UTC |
Carey John FVP of Operations
|
Exercise / conversionCommon Stock | 36 | $0.28 | $10.08 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 9 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 22:33 UTC |
Carey John FVP of Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · derivative · entry 13 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 10,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 22:33 UTC |
Carey John FVP of Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,800 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · derivative · entry 12 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,800 shares Expires 2023-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 22:33 UTC |
Carey John FVP of Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,237 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · derivative · entry 11 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36 Underlying: Common Stock · 6,237 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 22:33 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 10,000 | $63.50 | $635,000.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 8 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,808 F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.50 to $63.55, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 22:33 UTC |
Carey John FVP of Operations
|
Exercise / conversionCommon Stock | 10,000 | $38.46 | $384,600.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 7 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 22:33 UTC |
Carey John FVP of Operations
|
Exercise / conversionCommon Stock | 6,800 | $0.28 | $1,904.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 6 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 22:33 UTC |
Carey John FVP of Operations
|
Exercise / conversionCommon Stock | 6,237 | $0.28 | $1,746.36 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 5 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 17:29 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 11,051 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-22-037661 · doc4.xml · derivative · entry 4 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,051 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 17:29 UTC |
Khayal Tamer IChief Commercial Officer
|
Exercise / conversionCommon Stock | 11,051 | $2.21 | $24,422.71 |
DisclosureSEC source: 0000899243-22-037661 · doc4.xml · nonDerivative · entry 1 Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By the Tamer Ibrahim Ahmed Khayal Trust Disclosed balance after: 11,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC |
Carey John FVP of Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · derivative · entry 10 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,273 Underlying: Common Stock · 3,000 shares Expires 2023-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 100 | $62.45 | $6,245.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 771 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 1,403 | $61.70 | $86,565.10 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 871 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.29 to $61.99, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC |
Carey John FVP of Operations
|
SaleCommon Stock | 1,497 | $60.83 | $91,062.51 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,274 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.23 to $61.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:33 UTC |
Carey John FVP of Operations
|
Exercise / conversionCommon Stock | 3,000 | $0.28 | $840.00 |
DisclosureSEC source: 0000899243-22-037665 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:30 UTC |
Gordon StephenChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-22-037662 · doc4.xml · derivative · entry 4 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,728 Underlying: Common Stock · 10,000 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:30 UTC |
Gordon StephenChief Financial Officer
|
SaleCommon Stock | 31 | $62.15 | $1,926.65 |
DisclosureSEC source: 0000899243-22-037662 · doc4.xml · nonDerivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,714 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.10 to $62.15, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:30 UTC |
Gordon StephenChief Financial Officer
|
SaleCommon Stock | 9,969 | $61.30 | $611,099.70 |
DisclosureSEC source: 0000899243-22-037662 · doc4.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,745 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.05 to $62.04, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:30 UTC |
Gordon StephenChief Financial Officer
|
Exercise / conversionCommon Stock | 10,000 | $16.14 | $161,400.00 |
DisclosureSEC source: 0000899243-22-037662 · doc4.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 23, 2022 Filed Nov 23, 2022 21:30 UTC |
Lovell StephanieDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,657 | $0.00 Strike: $47.82 | $0.00 |
DisclosureSEC source: 0000899243-22-036935 · doc4.xml · derivative · entry 9 Lovell Stephanie · CIK 0001772054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,543 Underlying: Common Stock · 5,657 shares Expires 2031-03-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested as to one-third of the shares subject to the option on March 22, 2022 and vests in equal monthly installments as to the remainder of the shares for two years thereafter. Read SEC document |
| November 23, 2022 Filed Nov 23, 2022 21:30 UTC |
Lovell StephanieDirector
|
SaleCommon Stock | 5,657 | $59.50 | $336,591.50 |
DisclosureSEC source: 0000899243-22-036935 · doc4.xml · nonDerivative · entry 6 Lovell Stephanie · CIK 0001772054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 23, 2022 Filed Nov 23, 2022 21:30 UTC |
Lovell StephanieDirector
|
Exercise / conversionCommon Stock | 5,657 | $47.82 | $270,517.74 |
DisclosureSEC source: 0000899243-22-036935 · doc4.xml · nonDerivative · entry 5 Lovell Stephanie · CIK 0001772054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:30 UTC |
Lovell StephanieDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $26.26 | $0.00 |
DisclosureSEC source: 0000899243-22-036935 · doc4.xml · derivative · entry 8 Lovell Stephanie · CIK 0001772054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,150 Underlying: Common Stock · 1,100 shares Expires 2031-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested as to one-third of the shares subject to the option on March 22, 2022 and vests in equal monthly installments as to the remainder of the shares for two years thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.